CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907

被引：1
|
作者：
Partridge, A. H.
Archer, L. E.
Kornblith, A. B.
Gralow, J. R.
Grenier, D.
Perez, E. A.
Wolff, A. C.
Hudis, C. A.
Winer, E. P.
Muss, H.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA
[5] Johns Hopkins Univ, Baltimore, MD USA
[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[7] Univ Vermont, Burlington, VT USA
[8] Vermont Canc Ctr, Burlington, VT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6542
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6542
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104
    Partridge, Ann H.
    Archer, Laura
    Kornblith, Alice B.
    Gralow, Julie
    Grenier, Debjani
    Perez, Edith
    Wolff, Antonio C.
    Wang, Xiaofei
    Kastrissios, Helen
    Berry, Donald
    Hudis, Clifford
    Winer, Eric
    Muss, Hyman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : 2418 - 2422
  • [2] Adherence, Persistence and Toxicity with Oral CMF in Older Women with Early Stage Breast Cancer in CALGB 49907 (Adherence Companion Study 60104)
    Ruddy, K. J.
    Archer, L. E.
    Cohen, H. J.
    Winer, E. P.
    Hudis, C. A.
    Muss, H. B.
    Partridge, A. H.
    [J]. CANCER RESEARCH, 2010, 70
  • [3] Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
    Ruddy, K. J.
    Pitcher, B. N.
    Archer, L. E.
    Cohen, H. J.
    Winer, E. P.
    Hudis, C. A.
    Muss, H. B.
    Partridge, A. H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (12) : 3075 - 3081
  • [4] Changes in Cognitive Function in Older Women With Breast Cancer Treated with Standard Chemotherapy and Capecitabine within CALGB 49907
    Freedman, R. A.
    Pitcher, B.
    Keating, N. L.
    Barry, W. T.
    Balman, K. V.
    Kornblith, A.
    Mandelblatt, J.
    Kimmick, G. G.
    Hurria, A.
    Winer, E. P.
    Hudis, C. A.
    Cohen, H. J.
    Muss, H. B.
    [J]. CANCER RESEARCH, 2012, 72
  • [5] Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance)
    Klepin, Heidi D.
    Pitcher, Brandelyn N.
    Ballman, Karla V.
    Kornblith, Alice B.
    Hurria, Arti
    Winer, Eric P.
    Hudis, Clifford
    Cohen, Harvey J.
    Muss, Hyman B.
    Kimmick, Gretchen G.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (05) : E285 - E292
  • [6] Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907
    Muss, H. B.
    Berry, D. L.
    Cirrincione, C.
    Theodoulou, M.
    Mauer, A.
    Cohen, H.
    Partridge, A. H.
    Norton, L.
    Hudis, C. A.
    Winer, E. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907
    Muss, Hyman B.
    Berry, Donald A.
    Cirrincione, Constance T.
    Theodoulou, Maria
    Hurria, Arti
    Cohen, Harvey Jay
    Partridge, Ann
    Norton, Larry
    Hudis, Clifford A.
    Winer, Eric P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial
    Muss, Hyman B.
    Polley, Mei-Yin C.
    Berry, Donald A.
    Liu, Heshan
    Cirrincione, Constance T.
    Theodoulou, Maria
    Mauer, Ann M.
    Kornblith, Alice B.
    Partridge, Ann H.
    Dressler, Lynn G.
    Cohen, Harvey J.
    Kartcheske, Patricia A.
    Perez, Edith A.
    Wolff, Antonio C.
    Gralow, Julie R.
    Burstein, Harold J.
    Mahmood, Ahmad A.
    Sutton, Linda M.
    Magrinat, Gustav
    Parker, Barbara A.
    Hart, Ronald D.
    Grenier, Debjani
    Hurria, Arti
    Jatoi, Aminah
    Norton, Larry
    Hudis, Clifford A.
    Winer, Eric P.
    Carey, Lisa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (26) : 2338 - +
  • [9] Quality of Life of Early Stage Breast Cancer Patients 65 Years Old or Older Randomized to Standard Chemotherapy or Capecitabine: A Cancer and Leukemia Group B Study (CALGB 49907).
    Kornblith, A. B.
    Archer, L.
    Lan, L.
    Kimmick, G.
    Partridge, A.
    Casey, R.
    Bennett, S.
    Hudis, C.
    Winer, E.
    Cohen, H. J.
    Muss, H. B.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 776S - 776S
  • [10] Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901
    Sheppard, Vanessa B.
    Faul, Leigh Anne
    Luta, George
    Clapp, Jonathan D.
    Yung, Rachel L.
    Wang, Judy Huei-yu
    Kimmick, Gretchen
    Isaacs, Claudine
    Tallarico, Michelle
    Barry, William T.
    Pitcher, Brandelyn N.
    Hudis, Clifford
    Winer, Eric P.
    Cohen, Harvey J.
    Muss, Hyman B.
    Hurria, Arti
    Mandelblatt, Jeanne S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (22) : 2318 - U198
12345